Explore
Antimicrobial Therapy in Intensive Care Unit
0 Ungluers have
Faved this Work
Login to Fave
This reprint is an excellent collection of articles that deal with difficult-to-treat infections in the ICU environment. Multiresistant bacteria and fungi create severe treatment problems to the physician charged with their care. We hope that this book will help everyday dilemmas and add useful information on difficult topics.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 36 times via unglue.it ebook links.
- 36 - pdf (CC BY) at Unglue.it.
Keywords
- Acinetobacter
- Acinetobacter baumannii
- antibiotic choices
- antibiotic optimisation
- antibiotic pressure
- antibiotic resistance
- antibiotic stewardship (AMS)
- antibiotics
- antibiotics utilization
- antimicrobial agents
- antimicrobial combinations
- antimicrobial stewardship
- APACHE II score
- aspiration pneumonia
- bacteraemia
- bacteremia
- beta-lactam antibiotics
- biomarker
- blood stream infection
- bloodstream infection
- broth microdilution
- C-reactive protein
- Candida species
- candidemia
- carbapenem-resistant A. baumannii (CRAb)
- carbapenems
- cefiderocol
- clinical pharmacy services
- colistin
- colistin-resistant
- Colonization
- COVID-19
- Critical Illness
- Critically ill
- de-escalation
- defined daily dose
- double carbapenem
- dysbiosis
- ECMO
- empiric
- Empirical
- Epidemiology
- eravacycline
- extracorporeal membrane oxygenation
- fluconazole resistance
- Gram-negative
- guided antimicrobial therapy
- HAP
- hospital-acquired pneumonia (HAP)
- ICU
- incidence
- Infection
- infection control
- intensive care
- intensive care unit
- Klebsiella pneumoniae
- mechanical ventilation
- medicine
- microbiome
- Monte Carlo simulation
- Mortality
- multidrug-resistance (MDR)
- n/a
- newer β-lactam-β-lactamase inhibitors
- non-albicans Candida species
- non-fermentative Gram-negative bacilli (GNB)
- pandrug-resistant
- Pharmacodynamics
- pharmacokinetics
- pneumonia resolution
- polymicrobial
- Presepsin
- probabilistic antibiotics
- Probiotics
- procalcitonin
- Pseudomonas aeruginosa
- renal replacement therapy
- Risk factors
- salvage treatment
- SARS-CoV-2 infection
- Sepsis
- septic shock
- SOFA score
- source control
- synergy
- VAP
- ventilator-associated pneumonia
- ventilator-associated pneumonia (VAP)
Links
DOI: 10.3390/books978-3-0365-6768-6Editions